carnitine has been researched along with Thymoma in 1 studies
Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanism(s) of immune checkpoint inhibitor (ICI)-induced myasthenia gravis (MG), an immune-related adverse event (irAE) that is fatal and limits subsequent ICI use, remain unexplored." | 1.72 | Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis. ( Chen, L; Gao, W; Gong, Q; Guo, R; Jin, S; Li, J; Liu, X; Shao, YW; Shen, L; Sun, C; Wang, Q; Wang, W; Wang, Z; Wu, L; Xu, J; Yin, JC; Zhang, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W | 3 |
| Wu, L | 3 |
| Jin, S | 3 |
| Li, J | 3 |
| Liu, X | 3 |
| Xu, J | 3 |
| Zhang, W | 3 |
| Gong, Q | 3 |
| Sun, C | 3 |
| Wang, W | 3 |
| Wang, Z | 3 |
| Shao, YW | 3 |
| Yin, JC | 3 |
| Shen, L | 3 |
| Chen, L | 3 |
| Wang, Q | 3 |
| Guo, R | 3 |
1 other study available for carnitine and Thymoma
| Article | Year |
|---|---|
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |